Pat Lopath is co-founder and chief operating officer of TECLens. He leads the technical team, striving to inspire the same entrepreneurial spirt and passion for TECLens’ revolutionary refractive correction technology that led him to co-found the company along with Drs. Roy Chuck and David Acker.

He has spent 25 years in healthcare, working across the medical device and pharmaceutical sectors at various levels to optimize product development cycles while focusing on patient outcomes. Pat is an innovative engineer, holding 25 U.S. patents.

Pat earned a BSE in biomedical engineering and an MBA from Duke University and a M.S. in bioengineering from Penn State.